Shanghai RAAS Blood Products Co., Ltd.
Status: Publicly traded
Direct answer
Shanghai RAAS Blood Products Co., Ltd. is publicly traded on SHZ under the ticker 002252.SZ.
Shanghai RAAS Blood Products Co., Ltd. engages in the research, development, production, and sale of blood products. It provides human albumin, intravenous injection of human immunoglobulin, coagulation factor products, vaccines, diagnostic reagents, and testing services. The company was founded by Kieu Hoang on October 29, 1988 and is headquartered in Shanghai, China.
Can you invest in Shanghai RAAS Blood Products Co., Ltd.?
Yes. Shanghai RAAS Blood Products Co., Ltd. is publicly traded on SHZ under the ticker 002252.SZ.
View deeper analysis
View detailed research on MarketSnap, including financials, valuation tools, and analyst context.
Open research for Shanghai RAAS Blood Products Co., Ltd.
Detailed equity research is provided by MarketSnap.